Sales Practices
Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Pending actions
13
Historical total
15
Resolved / remanded
2
Active. A substantial share of actions remain pending. Of 15 lawsuits ever part of this litigation, 13 remain active.
About this litigation
Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Sales Practices docket. It was centralized on April 7, 2016 before Gregory K. Frizzell, Chief Judge, USDC, in the N.D. Oklahoma.
As of the August 3, 2026 JPML report, 13 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Sales Practices MDLs
View categoryInsulin Pricing Litigation
514
pending actions
MDL 3080
D. New Jersey
Dividend Solar Finance, LLC, and Fifth Third Bank Sales and Lending Practices Litigation
42
pending actions
MDL 3128
D. Minnesota
Santa Fe Natural Tobacco Company Marketing and Sales Practices Litigation
17
pending actions
MDL 2695
D. New Mexico
General Motors Air Conditioning Marketing and Sales Practices Litigation
15
pending actions
MDL 2818
E.D. Michigan